Invention Grant
US08236819B2 Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
有权
二氢 - [1H] - 喹啉-2-酮衍生物作为用于治疗血脂异常，高胆固醇血症和糖尿病的RXR激动剂
![Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes](/docs/US/2012-08-07/US08236819B2/abs.jpg.600x600.jpg)
- Patent Title: Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
- Patent Title (中): 二氢 - [1H] - 喹啉-2-酮衍生物作为用于治疗血脂异常，高胆固醇血症和糖尿病的RXR激动剂
-
Application No.: US12617776Application Date: 2009-11-13
-
Publication No.: US08236819B2Publication Date: 2012-08-07
- Inventor: Bharat Lagu , Rimma Lebedev , Barbara Pio
- Applicant: Bharat Lagu , Rimma Lebedev , Barbara Pio
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica N.V.
- Current Assignee: Janssen Pharmaceutica N.V.
- Current Assignee Address: BE Beerse
- Main IPC: A61K31/47
- IPC: A61K31/47 ; C07D215/20
![Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes](/abs-image/US/2012/08/07/US08236819B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating RXR mediated disorders. More particularly, the compounds of the present invention are RXR agonists useful for treating RXR mediated disorders.
Public/Granted literature
Information query
